Chapter 5- Assessing the Validity and Reliability of Diagnostic Screening Tests Flashcards

1
Q

Bimodal curve

A

A graph with 2 peaks. However, most human characteristics are not bimodal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Validity

A

The ability of a test to determine who has a disease and who does not. It has 2 components- sensitivity and specificity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Sensitivity

A

The ability of the test to correctly identify who has a disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Specificity

A

The ability of the test to correctly identify who does NOT have a disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Risks of false positives

A

People who test positive may have to undergo more expensive and maybe more invasive testing. It may place unnecessary burdens on the healthcare system. Also, it causes stress for the patient who thinks that they have that specific disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Risks of false negatives

A

If the disease being screened for is serious and has effective intervention, false negatives can delay diagnosis and negatively impact the patient’s outcome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cutoff level

A

This is necessary if a test doesn’t have a positive or negative result- there is no such thing as a “positive” blood pressure because it is a continuous variable. In this case, a unimodal curve is most common. It must be determined which blood pressure levels qualify as hypertension or hypotension. If the level is too high, people may be falsely considered negative when they actually do have hypertension. The cutoff level essentially determines sensitivity or specificity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Trade-off between sensitivity and specificity

A

If we increase the sensitivity by lowering the cutoff level, we decrease the specificity. However, if the cutoff level is raised to increase the specificity, the sensitivity will decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Sequential testing

A

Two stage testing, where tests are done one after the other. A less expensive, less invasive, or less uncomfortable test is conducted first. Those who test positive are recalled for another testing that might be more invasive but may have greater sensitivity or specificity. The goal in bringing people back for additional testing is to reduce the issue of false positives. These tests are frequently used for screening programs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Simultaneous testing

A

When both tests are conducted at the same time. This may be done with clinical workups, like when people are being admitted to the hospital. Results are interpreted as positive if the patient is positive on either test, and negative if negative on all tests

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Screening tests

A

Tests performed on asymptomatic
patients. Goal is to evaluate likelihood of
disease with the goal of early
detection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Diagnostic tests

A

Tests performed on symptomatic
individuals –or– persons with
abnormal screening tests. Goal is to establish presence or absence of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Dichotomous tests

A

Tests that have either a positive or negative result

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Impact of sequential testing on sensitivity and specificity

A

With sequential testing, there is a loss in net sensitivity. There is a gain in net specificity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Impact of simultaneous testing on sensitivity and specificity

A

There is a net gain in sensitivity and a net loss in specificity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Positive predictive value (PPV)

A

If the test results are positive for the patient, what is the probability that the patient has the disease?

17
Q

Negative predictive value (NPV)

A

If the test result is negative, what is the probability that the patient does not have the disease?

18
Q

2 factors that affect PPV

A
  1. The prevalence of the disease in the population tested
  2. The specificity of the test being used- in situations when the disease is infrequent
19
Q

Intrasubject variation

A

How an individual patient’s test results can vary over time. For example, a person’s blood pressure can be different depending on the time of day

20
Q

Intraobserver variation

A

Variation that occurs between 2 or more readings of the same test results made by the same observer. If a radiologist reads the same group of X-Rays at 2 different times, how will the results change?

21
Q

Interobserver variation

A

The variation between observers- two examiners may not give the same result

22
Q

Reliability

A

Ability to get the same results if the test is repeated. There are 2 measures- percent agreement and the kappa statistic

23
Q

Percent agreement

A

Does not account for agreement between observations due to “chance”

24
Q

Kappa statistic

A

Accounts for agreement between observations due to “chance”. Less than 40% is poor agreement, greater than 40% is intermediate to good

25
Q

When is disease detection worthwhile?

A

“Bear” diseases are dangerous, but move slowly enough to catch. These diseases benefit the most from screening programs. “Birds” move too quickly to be caught, and it will be too late to treat. “Turtles” move too slowly to ever be dangerous, and don’t need treatment.

26
Q

Lead-time bias

A

Occurs when a disease is detected by a screening or surveillance test at an earlier time point than it would have been if it had been diagnosed by its clinical appearance. This time lag or “lead time” during which the disease is asymptomatic is not taken into account during the survival analysis